TrialNature medicine2018
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
Christian U Blank et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
474 papers cite itlatest 60 shown
this paperpooled ittrialcites it